SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns blowout quarterly results and stronger outlook, alongside managements view that AI-driven memory supply will remain tight through fiscal 2028, are driving attention. Traders are split over the muted share-price response: bulls see durable demand and further earnings potential, while skeptics cite lofty expectations, rising costs, memory-cycle risk and higher yields.

Corteva, Inc. is a global pure-play agriculture company that combines innovative technologies, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. It generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. The company leverages recognized agricultural brands and a robust technology pipeline to maximize productivity for farmers while working with stakeholders throughout the food system to fulfill its promise of enriching the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva was founded in 1802 and is headquartered in Indianapolis, IN.

Corteva Inc

Cortevas completed separation of its seed business into Vylor (VYLR) prompted a sharp, mechanically adjusted drop in CTVA as it became the standalone crop-protection company. Traders are debating whether the selloff overstates the remaining businesss value, with some expecting a rebound while others remain cautious amid trading halts and uncertainty over VYLRs valuation.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs move to place VantageScore alongside FICO in mortgage pricing, alongside Rocket Mortgages planned use of VantageScore for eligible loans, has traders questioning FICOs mortgage-scoring moat and pricing power. Bears see a lasting competitive threat, while dip buyers argue the selloff overstates the risk because lender adoption and the impact on FICOs business remain uncertain.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

A Delaware court ruled that Liquidias Yutrepia infringes two United Therapeutics patent claims covering PH-ILD treatment, raising the possibility of losing that indication or facing broader sales restrictions; Liquidia plans to appeal and pursue a label change, while final remedies remain uncertain. Traders are sharply divided between viewing the selloff as an overreaction with PAH business still intact and fearing the ruling could severely damage Yutrepias prospects.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBMs self-hosted deployment option for its IBM Bob agentic AI platform is driving attention, with traders highlighting enterprise demand for on-premises and tightly governed AI while some question whether the product will materially affect the business. The announcement prompted bullish momentum trading, alongside calls to fade the move or take profits.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accentures quarterly earnings beat, record annual bookings and revenue-growth outlook have driven a sharp rally, with traders treating bookings as evidence that enterprise consulting demand is holding up despite AI-disruption concerns. Bulls see the results as easing those fears, while skeptics argue growth remains modest and question whether the rally will last.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMYs sharp rebound and move back above the half-cent level have fueled breakout talk and renewed buying, with bullish traders pointing to the PanasonicJasmy Smart Render collaboration and developing JasmyChain/AI utility as supporting context. Others remain skeptical that partnership and infrastructure progress will translate into real adoption, and debate whether the price move can hold amid recent exchange-delisting concerns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A high-volume breakout above resistance has put IBRX in focus, but traders debate whether momentum and institutional buying can hold or the shares will pull back. Many speculate about short covering and upcoming Anktiva label expansion, though no new announcement is confirmed.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs largest-ever commercial Electron deala 20-launch agreement with Synspectivehas put its growing launch backlog and customer demand at the center of discussion. Many traders view the contract as a bullish business signal, while others question its undisclosed financial terms and warn that the initial share-price pop could fade.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are under pressure amid staged IPO lockup expirations and insider selling, alongside reports that OpenAIs latest Ultrafast tier is using Nvidia GPUs rather than Cerebras hardware. Bears see added share supply and questions about the OpenAI relationship as headwinds, while bulls argue the reports do not negate the broader customer commitments and AI-inference demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aimei Health Technology (NASDAQ:AFJK) Trading Down 2.2% - Should You Sell?

Aimei Health Technology (NASDAQ:AFJK) Shares Down 2.2% - Should You Sell...

Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 4.2% - Here's Why

Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 4.2% - Time to Buy...

61,043 Shares in Aimei Health Technology Co., Ltd. $AFJK Purchased by Clear Street Group Inc.

Clear Street Group Inc. bought a new stake in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with...

Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 0.4% - Should You Buy?

Aimei Health Technology (NASDAQ:AFJK) Trading 0.4% Higher - Should You Buy...

Aimei Health Technology (NASDAQ:AFJK) Upgraded at Wall Street Zen

Wall Street Zen raised shares of Aimei Health Technology to a "sell" rating in a research note on Saturday...

Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 11% - Here's What Happened

Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 11% - Time to Buy...

Aimei Health Technology (NASDAQ:AFJK) Shares Gap Down - Here's Why

Aimei Health Technology (NASDAQ:AFJK) Shares Gap Down - Here's What Happened...

Aimei Health Technology (NASDAQ:AFJK) Shares Gap Up - Here's What Happened

Aimei Health Technology (NASDAQ:AFJK) Shares Gap Up - Should You Buy...

Aimei Health Technology (NASDAQ:AFJK) Sets New 52-Week High - Here's What Happened

Aimei Health Technology (NASDAQ:AFJK) Hits New 1-Year High - Should You Buy...

Aimei Health Technology (NASDAQ:AFJK) Sees Unusually-High Trading Volume - Here's Why

Aimei Health Technology (NASDAQ:AFJK) Sees Strong Trading Volume - Here's Why...

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$12.11
Prev Close	$12.04
Open	$12.10
Dividend Yield	0.00%
50-Day Moving Average	$12.11
Beta	0.02
Avg. Volume	20,441.66
PE Ratio	174.50

52-Week High	$130.37
52-Week Low	$6.75
Market Capitalization	$38.34M
EPS (Annual)	$0.1717
Price to Book	4.79
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

AFJK Fundamentals